The United States Patent and Trademark Office (USPTO) today announced further extensions to the time allowed to file certain patent and trademark-related documents and to pay certain required fees. These actions are an exercise of temporary authority provided to the USPTO by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) signed by President Trump on March 27.
The United States Patent and Trademark Office (USPTO) today announced that it will use provisions of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), to extend the time to file certain patent and trademark-related documents and to pay certain required fees.
The content below represents all the public messaging the USPTO has released related to coronavirus (COVID-19).Relief for USPTO customers affected by COVID-19The United States Patent and Trademark Office (USPTO) considers the effects of coronavirus to be an “extraordinary situation” within the meaning of 37 CFR 1.183 and 37 CFR 2.146 for affected patent and trademark applicants, patentees, reexamination parties, and trademark owners. Therefore, the USPTO is waiving petition fees in certain situations for customers impacted by the coronavirus.
米国特許商標庁は、コロナウイルスの影響で遅延することとなった手続の延長を認めるものではないが、そのための回復請求(petition)については無料とする決定をしています。また、来週26日からは庁内で一般公衆に公開しているエリアを期限的に閉鎖するものとしています。㋂13日以降の審査官、審判官との面談等はビデオ又は電話会議になるとのことです。(USPTO changes rules due to COVID-19)
Are You Ready For USPTO’s New Mandatory Electronic Filing Email Requirements?Thursday, February 13, 2020The U.S. Patent and Trademark Office’s (USPTO) new Mandatory Electronic Filing and Email Address Requirements go into effect on Feb. 15, 2020. As a result of these requirements, any new U.S. trademark applications must include an email address for each applicant, even if there is an appointed attorney on record.
CNBC's @eschulze recently visited the #USPTO to talk intellectual property with Director Andrei Iancu. Go to https://t.co/f6tJtxqQIH to learn more about why trademarks and patents are so valuable.
Speaker Series: Joseph Marron
Speaker Series: Lonnie Johnson
Speaker Series: Temple Grandin
Speaker Series: Vint Cerf
Speaker Series: Martine Rothblatt
Speaker Series: Dean Kamen
A conversation with Shawn Springs
Speaker Series: Marian Croak
USPTO Director’s Speaker Series: A fireside chat with the U.S. Surgeon General Dr. Vivek Murthy
A San Diego biotechnology company has been refused a trademark registration for ‘Sequencing by Binding’ on the grounds that it is too descriptive. Omniome, which develops DNA sequencing tools, filed for the mark in 2017 but had its application refused by an examining attorney at the US Patent and Trademark Office (USPTO). In a precedential decision, issued on Monday, January 6, the USPTO’s Trademark Trial and Appeal Board (TTAB) upheld the original decision, concluding that ‘Sequencing by Binding’ was descriptive of the claimed goods and services.
The U.S. Patent and Trademark Office (USPTO) has delayed the deadline for mandatory electronic filing of trademarks from December 21 to February 15 after receiving feedback from the public, the agency announced in a Federal Register
The USPTO has recently released its latest trademark fee proposal for 2020. The proposal includes substantial increases to many existing fees, and over 20 brand new fees for actions previously available at no cost. The primary purpose of these changes is to preserve and maintain the integrity of the Register by ensuring applicants adhere to U.S. specification and use requirements and to recoup more of the costs associated with TTAB proceedings.